Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo

Circ Res. 2005 Apr 1;96(6):635-42. doi: 10.1161/01.RES.0000160610.61306.0f. Epub 2005 Feb 24.

Abstract

Mechanotransduction represents an integral part of vascular homeostasis and contributes to vascular lesion formation. Previously, we demonstrated a mechanosensitive activation of phosphoinositide 3-kinase (PI3-K)/protein kinase B (Akt) resulting in p27Kip1 transcriptional downregulation and cell cycle entry of vascular smooth muscle cells (VSMC). In this study, we further elucidated the signaling from outside-in toward PI3-K/Akt in vitro and in an in vivo model of elevated tensile force. When VSMC were subjected to cyclic stretch (0.5 Hz at 125% resting length), PI3-K, Akt, and Src kinases were found activated. Disrupting caveolar structures with beta-cyclodextrin or transfection of VSMC with caveolin-1 antisense oligonucleotides (ODN) prevented PI3-K and Akt activation and cell cycle entry. Furthermore, PI3-K and Akt were resistant to activation when Src kinases were inhibited pharmacologically or by overexpression of a kinase-dead c-Src mutant. alpha(V)beta3 integrins were identified to colocalize with PI3-K/caveolin-1 complexes, and blockade of alpha(V)beta3 integrins prevented Akt activation. The central role of caveolin-1 in mechanotransduction was further examined in an in vivo model of elevated tensile force. Interposition of wild-type (WT) jugular veins into WT carotid arteries resulted in a rapid Akt activation within the veins that was almost abolished when veins of caveolin-1 knockout (KO) mice were used. Furthermore, late neointima formation within the KO veins was significantly reduced. Our study provides evidence that PI3-K/Akt is critically involved in mechanotransduction of VSMC in vitro and within the vasculature in vivo. Furthermore, caveolin-1 is essential for the integrin-mediated activation of PI3-K/Akt.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anastomosis, Surgical
  • Androstadienes / pharmacology
  • Animals
  • Aorta / cytology
  • Carotid Artery, Common / surgery
  • Caveolae / drug effects
  • Caveolae / physiology
  • Caveolae / ultrastructure
  • Caveolin 1
  • Caveolins / deficiency
  • Caveolins / genetics
  • Caveolins / physiology*
  • Cells, Cultured / enzymology
  • Cells, Cultured / physiology
  • Cholesterol / metabolism
  • Chromones / pharmacology
  • Enzyme Activation
  • Extracellular Signal-Regulated MAP Kinases / physiology
  • Focal Adhesions / metabolism
  • Integrin alphaVbeta3 / physiology
  • Jugular Veins / transplantation
  • Male
  • Membrane Lipids / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Morpholines / pharmacology
  • Muscle, Smooth, Vascular / cytology
  • Myocytes, Smooth Muscle / enzymology
  • Myocytes, Smooth Muscle / physiology
  • Phosphatidylinositol 3-Kinases / physiology*
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Serine-Threonine Kinases / physiology*
  • Proto-Oncogene Proteins / physiology*
  • Proto-Oncogene Proteins c-akt
  • Proto-Oncogene Proteins pp60(c-src) / physiology
  • Pyrazoles / pharmacology
  • Pyrimidines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / physiology*
  • Stress, Mechanical*
  • Tunica Intima / pathology
  • Wortmannin
  • beta-Cyclodextrins / pharmacology

Substances

  • 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine
  • Androstadienes
  • Cav1 protein, mouse
  • Cav1 protein, rat
  • Caveolin 1
  • Caveolins
  • Chromones
  • Integrin alphaVbeta3
  • Membrane Lipids
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins
  • Pyrazoles
  • Pyrimidines
  • beta-Cyclodextrins
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Cholesterol
  • Proto-Oncogene Proteins pp60(c-src)
  • Akt1 protein, rat
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
  • betadex
  • Wortmannin